Company / Return on Equity (ROE)
60 DEGREES PHARMACEUTICALS, INC. Return on Equity (ROE) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-229.5%
FY2025
5-year range
-229.5% / -93.3%
FY2023-FY2025
Trend
-145.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
60 DEGREES PHARMACEUTICALS, INC. reports negative total equity of -229.5% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-229.5% in FY2025.
Declined from -126.9% to -229.5% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 145.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -229.5% | -145.9% |
| FY2024 | -93.3% | +26.5% |
| FY2023 | -126.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026